AIDS Meds: Founded & Operated by People with HIVPOZ logo
Back to home » Treatment News » Top Stories

emailrssprint

Innate Factors May Block HIV in Women

November 17, 2006

(Reuters Health) - Upregulation of certain immunologic factors could account for the continued seronegativity of African commercial sex workers at high risk of HIV infection, according to researchers.

In the October 1st issue of the Journal of Acquired Immune Deficiency Syndromes, Dr. Taha Hirbod of the Karolinska Institute, Stockholm and colleagues note that the endogenous factors that mediate resistance to HIV transmission are still not widely explored.

"High-risk sexual practices," Dr. Hirbod told Reuters Health, "seem to alter the expression of certain innate molecules but not others, and these alterations do not necessarily increase the risk of HIV acquisition."

To investigate further, the researchers examined cervical biopsy samples from 7 HIV-negative African sex workers, 6 white HIV-positive women, who had been characterized as non-transmitters, and 10 HIV-negative controls.

Compared to the low-risk controls, the women with HIV and the high-risk sex workers had a higher expression of interferon-alpha and RANTES. More than 90% of the RANTES-expressing cells were CD8+ cells.

The researchers note that it is not possible to distinguish whether the observed upregulation was due to exposure to HIV or to other STDs.

However, they conclude that pre-existing interferon-alpha and RANTES "may be of clinical importance for protection against HIV1 at mucosal exposure."

In fact, Dr. Hirbod added, "I believe our findings highlight the importance of future studies conducted on mucosal sites as these will probably correctly guide us when constructing potential microbicide or vaccine candidates."

J Acquir Immune Defic Syndr 2006;43:137-143.



Copyright © 2006 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

emailrssprint



[Go to top]



Most Popular Stories

CD4s Predictive of Non-AIDS-Related Health Problems

HIV Immunotherapy Shows Promise

Slim for Summer: Safe and Sane Weight Loss

Hetero Men Also at Risk for Anal HPV

Treatment Failure: Symptoms Matter Too

Interfering with Immune Protein Slows HIV Reproduction


Most Popular Lessons

Herpes Simplex Virus

Syphilis & Neurosyphilis

Shingles

The HIV Life Cycle

Human Papilloma Virus (HPV)

What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Treatment News Archive

May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006


© 2008 Smart + Strong. All Rights Reserved. terms of use and your privacy